Clinical and serologic study of sjögren's syndrome in patients with progressive systemic sclerosis

Thaddeus A. Osial, Theresa L. Whiteside, Robert B. Buckingham, Gurmukh Singh, E. Leon Barnes, John M. Pierce, Gerald P. Rodnan

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Fifty‐eight patients with progressive systemic sclerosis (PSS) were evaluated clinically and by biopsy of the minor salivary glands of the lips for the presence of Sjögren'S syndrome. Clinical findings included dry eyes in 38%, dry mouth in 32%, parotid enlargement in 4%, and an abnormal Schirmer'S test in 34%. Histologic changes in lip biopsies included lymphocytic infiltrates characteristic of Sjögren'S syndrome in 17 individuals (29%). In 19 (33%) there was periglandular and intraglandular fibrosis (PSS‐fibrosis) without significant inflammation, an alteration characteristic of PSS per se. In the remaining 22 patients (38%) with PSS, no abnormality was found. Of those with PSS and Sjögren'S syndrome, 53% had serum antibodies to SS‐A and/or SS‐B, while only 1 patient with a normal biopsy had either of these antibodies. Anti‐SS‐A and anti‐SS‐B were not detected in patients with glandular fibrosis alone. The mortality rate of the PSS‐fibrosis group was higher due to a variety of severe internal manifestations related to PSS. Antibodies to SS‐A and SS‐B are useful serologic markers of the presence of Sjögren'S syndrome in patients with PSS.

Original languageEnglish (US)
Pages (from-to)500-508
Number of pages9
JournalArthritis & Rheumatism
Volume26
Issue number4
DOIs
StatePublished - Apr 1983

Fingerprint

Diffuse Scleroderma
Lip
Biopsy
Antibodies
Fibrosis
Minor Salivary Glands
Mouth
Clinical Studies
Inflammation
Mortality
Serum

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Cite this

Osial, T. A., Whiteside, T. L., Buckingham, R. B., Singh, G., Barnes, E. L., Pierce, J. M., & Rodnan, G. P. (1983). Clinical and serologic study of sjögren's syndrome in patients with progressive systemic sclerosis. Arthritis & Rheumatism, 26(4), 500-508. https://doi.org/10.1002/art.1780260408

Clinical and serologic study of sjögren's syndrome in patients with progressive systemic sclerosis. / Osial, Thaddeus A.; Whiteside, Theresa L.; Buckingham, Robert B.; Singh, Gurmukh; Barnes, E. Leon; Pierce, John M.; Rodnan, Gerald P.

In: Arthritis & Rheumatism, Vol. 26, No. 4, 04.1983, p. 500-508.

Research output: Contribution to journalArticle

Osial, TA, Whiteside, TL, Buckingham, RB, Singh, G, Barnes, EL, Pierce, JM & Rodnan, GP 1983, 'Clinical and serologic study of sjögren's syndrome in patients with progressive systemic sclerosis', Arthritis & Rheumatism, vol. 26, no. 4, pp. 500-508. https://doi.org/10.1002/art.1780260408
Osial, Thaddeus A. ; Whiteside, Theresa L. ; Buckingham, Robert B. ; Singh, Gurmukh ; Barnes, E. Leon ; Pierce, John M. ; Rodnan, Gerald P. / Clinical and serologic study of sjögren's syndrome in patients with progressive systemic sclerosis. In: Arthritis & Rheumatism. 1983 ; Vol. 26, No. 4. pp. 500-508.
@article{93a2d2e31e5b48dfac82664c28d0ec5b,
title = "Clinical and serologic study of sj{\"o}gren's syndrome in patients with progressive systemic sclerosis",
abstract = "Fifty‐eight patients with progressive systemic sclerosis (PSS) were evaluated clinically and by biopsy of the minor salivary glands of the lips for the presence of Sj{\"o}gren'S syndrome. Clinical findings included dry eyes in 38{\%}, dry mouth in 32{\%}, parotid enlargement in 4{\%}, and an abnormal Schirmer'S test in 34{\%}. Histologic changes in lip biopsies included lymphocytic infiltrates characteristic of Sj{\"o}gren'S syndrome in 17 individuals (29{\%}). In 19 (33{\%}) there was periglandular and intraglandular fibrosis (PSS‐fibrosis) without significant inflammation, an alteration characteristic of PSS per se. In the remaining 22 patients (38{\%}) with PSS, no abnormality was found. Of those with PSS and Sj{\"o}gren'S syndrome, 53{\%} had serum antibodies to SS‐A and/or SS‐B, while only 1 patient with a normal biopsy had either of these antibodies. Anti‐SS‐A and anti‐SS‐B were not detected in patients with glandular fibrosis alone. The mortality rate of the PSS‐fibrosis group was higher due to a variety of severe internal manifestations related to PSS. Antibodies to SS‐A and SS‐B are useful serologic markers of the presence of Sj{\"o}gren'S syndrome in patients with PSS.",
author = "Osial, {Thaddeus A.} and Whiteside, {Theresa L.} and Buckingham, {Robert B.} and Gurmukh Singh and Barnes, {E. Leon} and Pierce, {John M.} and Rodnan, {Gerald P.}",
year = "1983",
month = "4",
doi = "10.1002/art.1780260408",
language = "English (US)",
volume = "26",
pages = "500--508",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Clinical and serologic study of sjögren's syndrome in patients with progressive systemic sclerosis

AU - Osial, Thaddeus A.

AU - Whiteside, Theresa L.

AU - Buckingham, Robert B.

AU - Singh, Gurmukh

AU - Barnes, E. Leon

AU - Pierce, John M.

AU - Rodnan, Gerald P.

PY - 1983/4

Y1 - 1983/4

N2 - Fifty‐eight patients with progressive systemic sclerosis (PSS) were evaluated clinically and by biopsy of the minor salivary glands of the lips for the presence of Sjögren'S syndrome. Clinical findings included dry eyes in 38%, dry mouth in 32%, parotid enlargement in 4%, and an abnormal Schirmer'S test in 34%. Histologic changes in lip biopsies included lymphocytic infiltrates characteristic of Sjögren'S syndrome in 17 individuals (29%). In 19 (33%) there was periglandular and intraglandular fibrosis (PSS‐fibrosis) without significant inflammation, an alteration characteristic of PSS per se. In the remaining 22 patients (38%) with PSS, no abnormality was found. Of those with PSS and Sjögren'S syndrome, 53% had serum antibodies to SS‐A and/or SS‐B, while only 1 patient with a normal biopsy had either of these antibodies. Anti‐SS‐A and anti‐SS‐B were not detected in patients with glandular fibrosis alone. The mortality rate of the PSS‐fibrosis group was higher due to a variety of severe internal manifestations related to PSS. Antibodies to SS‐A and SS‐B are useful serologic markers of the presence of Sjögren'S syndrome in patients with PSS.

AB - Fifty‐eight patients with progressive systemic sclerosis (PSS) were evaluated clinically and by biopsy of the minor salivary glands of the lips for the presence of Sjögren'S syndrome. Clinical findings included dry eyes in 38%, dry mouth in 32%, parotid enlargement in 4%, and an abnormal Schirmer'S test in 34%. Histologic changes in lip biopsies included lymphocytic infiltrates characteristic of Sjögren'S syndrome in 17 individuals (29%). In 19 (33%) there was periglandular and intraglandular fibrosis (PSS‐fibrosis) without significant inflammation, an alteration characteristic of PSS per se. In the remaining 22 patients (38%) with PSS, no abnormality was found. Of those with PSS and Sjögren'S syndrome, 53% had serum antibodies to SS‐A and/or SS‐B, while only 1 patient with a normal biopsy had either of these antibodies. Anti‐SS‐A and anti‐SS‐B were not detected in patients with glandular fibrosis alone. The mortality rate of the PSS‐fibrosis group was higher due to a variety of severe internal manifestations related to PSS. Antibodies to SS‐A and SS‐B are useful serologic markers of the presence of Sjögren'S syndrome in patients with PSS.

UR - http://www.scopus.com/inward/record.url?scp=0020645460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020645460&partnerID=8YFLogxK

U2 - 10.1002/art.1780260408

DO - 10.1002/art.1780260408

M3 - Article

C2 - 6838673

AN - SCOPUS:0020645460

VL - 26

SP - 500

EP - 508

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 4

ER -